Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma - Peng, Li; Jiang, Yanyi; Chen, Hengxing; Wang, Yongqiang; Lan, Qiusheng; Chen, Shuiqin; Huang, Zhanwang; Zhang, Jingyuan; Tian, Duanqing; Qiu, Yuntan; Cai, Diankui; Peng, Jiangyun; et al. (Acta pharmaceutica Sinica. B, 2024)
Keywords: AJUBA; Core transcriptional regulatory circuitry; EHF; Enhancer; Gastroesophageal adenocarcinoma; KRAS pathway; EHF; Enhancer; Coactivator; Core transcriptional regulatory circuitry; Gastroesophageal adenocarcinoma; KRAS pathway; Gastric adenocarcinoma; Transcription factor; AJUBA; Esophageal adenocarcinoma; Lipid nanoparticles